Nalaganje...
Long non-coding RNA LINC00346 contributes to cisplatin resistance in nasopharyngeal carcinoma by repressing miR-342-5p
Cisplatin has been used as the first-line chemotherapy to treat advanced nasopharyngeal carcinoma (NPC), while acquired cisplatin resistance resulting from epigenetic regulation is not well understood. The relative expression of LINC00346 was detected in healthy persons, cisplatin-sensitive (CS) pat...
Shranjeno v:
| izdano v: | Open Biol |
|---|---|
| Main Authors: | , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
The Royal Society
2020
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7276527/ https://ncbi.nlm.nih.gov/pubmed/32397872 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1098/rsob.190286 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|